{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicmygsbp3nr2rpdhd7x3wbeucsuoud2hrpowwjjrhpdoocabd4e5a",
    "uri": "at://did:plc:2gbt2dlwaqovtnmxkat3tyke/app.bsky.feed.post/3mkrnnmcj2pl2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia6jql6nvgnvz5x6ajaexyblaldrvqab3qfwz2vrfwrw6digrtnhm"
    },
    "mimeType": "image/jpeg",
    "size": 192625
  },
  "path": "/articles/d41586-026-01398-8",
  "publishedAt": "2026-05-01T07:55:22.027Z",
  "site": "https://www.nature.com",
  "tags": [
    "doi:10.1038/d41586-026-01398-8"
  ],
  "textContent": "Nature, Published online: 30 April 2026; doi:10.1038/d41586-026-01398-8\n\nBlood cancer goes into remission for some people treated with a type of T cell that acts like stem cells.",
  "title": "Long-lived immune cells show promise against cancer in world-first trial",
  "updatedAt": "2026-04-30T00:00:00.000Z"
}